UK Markets open in 34 mins

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
40.34-1.70 (-4.04%)
At close: 04:00PM EDT
42.34 +2.00 (+4.96%)
After hours: 06:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close42.04
Bid0.00 x 1200
Ask0.00 x 900
Day's range39.05 - 41.73
52-week range27.65 - 133.82
Avg. volume1,502,585
Market cap4.101B
Beta (5Y monthly)0.66
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Why Shares of Guardant Health Dropped 33.6% in May

    It's a bit early for investors to jump the ship regarding Guardant because the biotech stock still has plenty of good long-term prospects. The test will compete with the Galleri blood-based cancer screening by the Grail unit of Illumina and a the Cologuard fecal screening by Exact Sciences. Investors are also watching the outcome of a lawsuit, filed in March by Illumina, that claims that Guardant and two of its founders -- former employees of Illumina -- used Illumina's propriety information to help them launch Guardant.

  • Simply Wall St.

    Insiders who placed huge bets on Guardant Health, Inc. (NASDAQ:GH) earlier this year would be disappointed with the 49% drop

    The recent price decline of 49% in Guardant Health, Inc.'s ( NASDAQ:GH ) stock may have disappointed insiders who...

  • Motley Fool

    Why Guardant Health Stock Is Crashing Today

    Shares of Guardant Health (NASDAQ: GH) were trading 23.4% lower as of 11:51 a.m. ET on Friday. The steep decline came after the company announced its first-quarter results following the market close on Thursday. This result was in line with Wall Street estimates.